Literature DB >> 9449200

Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids.

Z Huang1, M J Fasco, L S Kaminsky.   

Abstract

Inhibition of estrone sulfatase activity offers the potential for breast cancer prevention therapy by blocking a route to estrogen synthesis. We have investigated the inhibition of this activity by natural flavonoids in a human hepatic microsomal preparation in vitro. The majority of studies were performed with a male liver, but male and female livers exhibited comparable estrone sulfatase activities. The natural flavonoids, quercetin, kaempferol, and naringenin, significantly inhibited estrone sulfatase activity with I50 < 10 microM for the most potent, quercetin. Estrone sulfatase activity in the liver microsomes was biphasic, with a high affinity, low capacity, low concentration activity (Km 14.3 microM, Vmax 0.5 nmol/min/mg protein), probably steroid sulfatase-catalysed, and a low affinity, high capacity, high concentration activity (Km 1.5 mM, Vmax 21.5 nmol/min/mg protein), probably arylsulfatase C or E-catalysed. The former activity was inhibited uncompetitively by quercetin, the latter competitively. Quercetin, a natural dietary constituent, is a potent inhibitor of estrone sulfatase in vitro, and thus has the potential to express antiestrogenic activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449200     DOI: 10.1016/s0960-0760(97)00065-4

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  2 in total

Review 1.  Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women's health.

Authors:  Majorie B M van Duursen
Journal:  Toxicol Res (Camb)       Date:  2017-09-08       Impact factor: 3.524

2.  Flavonoid intake and breast cancer risk: a case--control study in Greece.

Authors:  J Peterson; P Lagiou; E Samoli; A Lagiou; K Katsouyanni; C La Vecchia; J Dwyer; D Trichopoulos
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.